Provided by Tiger Trade Technology Pte. Ltd.

Caris Life Sciences, Inc.

26.27
+1.696.88%
Post-market: 26.500.2300+0.88%19:53 EDT
Volume:6.39M
Turnover:165.58M
Market Cap:7.41B
PE:70.62
High:26.60
Open:24.73
Low:24.32
Close:24.58
52wk High:42.50
52wk Low:14.19
Shares:282.15M
Float Shares:116.00M
Volume Ratio:1.40
T/O Rate:5.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3720
EPS(LYR):-3.2200
ROE:20.13%
ROA:8.77%
PB:12.53
PE(LYR):-8.16

Loading ...

Press Release: AudioCodes Reports First Quarter 2026 Results

Dow Jones
·
May 05

BRIEF-Caris Life Sciences Receives Moldx Approval For Caris Chromoseq, Advancing Access To Comprehensive Genomic Profiling For Myeloid Malignancies

Reuters
·
May 04

Caris wins MolDX approval for ChromoSeq myeloid malignancy genome profiling test

Reuters
·
May 04

Earning Preview: Caris Life Sciences, Inc. revenue this quarter is expected to decrease by 28%, and institutional views are broadly bullish

Earnings Agent
·
May 01

Caris study validates AI signature predicting temozolomide benefit in glioblastoma patients

Reuters
·
Apr 29

Press Release: Horn Williamson Rebrands as Horn Williamson & Collins, Adds Matthew C. Collins as Named Partner

Dow Jones
·
Apr 29

A Look At Caris Life Sciences (CAI) Valuation As Shares Lose Momentum In Recent Months

Simply Wall St.
·
Apr 25

Caris Life Sciences announces annual shareholder meeting

Reuters
·
Apr 23

Caris Life Sciences to report first-quarter financial results, host webcast

Reuters
·
Apr 20

Hua An Insurance Announces CEO Resignation and Appointment of Interim Leader

Deep News
·
Apr 17

CAI Corp Updates Investors on March 2026 Net Asset Value

TIPRANKS
·
Apr 15

U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines

Reuters
·
Apr 14

Caris Life Sciences Initiated at Buy by Jefferies

Dow Jones
·
Apr 13

Jefferies Initiates Caris Life Sciences at Buy With $28 Price Target

MT Newswires Live
·
Apr 13

Caris Life Sciences initiated with a Buy at Jefferies

TIPRANKS
·
Apr 13

Caris Life Sciences Initiated at Neutral by Piper Sandler

Dow Jones
·
Apr 10

Caris Life Sciences initiated with a Neutral at Piper Sandler

TIPRANKS
·
Apr 10

U.S. RESEARCH ROUNDUP-Chevron, Littelfuse, Parker-Hannifin

Reuters
·
Apr 10

Caris Life Sciences Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Apr 07

Caris Life Sciences Inc - Credit Agreement Includes $400 Mln Term Loan, $300 Mln Delayed Draw, $500 Mln Incremental Facility - SEC Filing

THOMSON REUTERS
·
Apr 03